Geode Capital Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Geode Capital Management's CLBT Position: Q2 2026 in Review
Geode Capital Management increased its Cellebrite (CLBT) stake by 8.5% in Q2 2026, buying an estimated $446K and bringing the position to 428,874 shares worth $6.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2796.
Geode Capital Management first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.7M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Geode Capital Management held 428,874 shares of Cellebrite worth $6.26M as of Q2 2026.
- Geode Capital Management bought 33,749 Cellebrite shares in Q2 2026, an estimated $446K.
- Cellebrite made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2796 holding.
- Geode Capital Management first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
- Geode Capital Management's Cellebrite position peaked at $6.7M in Q4 2025.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.